1Li JJ. Enhancing anti-inflammatory cytokine IL - 10 may be beneficial for acute coronary syndrome. Med Hypotheses,2005,64:1023-1028.
2Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Meal,2004.350:1562-1564.
3Li JJ, Wang HR. Enhanced response of blood monocytes to C-renctive protein in patients with unstable angina. Clin Chim Acta,2005,352:127- 133.
4Li JJ, Jiang H, Huang CX, et al. Elevated C-reactive protein of plasma in patients with unstable angina: its relations with coronary stenosis and lipid profile. Angiology,2002,53:265 - 272.
5Li JJ, Li GS, Fang CH,et al. Activation of nuclear factor-(B and correlation with elevated plasma C - reactive protein in patients with unstable angina. Heat lung& Circulation,2004,13:173 - 178.
6Li JJ. Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis. Med Hypotheses, 2004, 63: 100-102.
7Maaeri A. Inflammation, atherosclerosis, and ischemic events: exploring the hidden side tithe raeon. N Engl J Med,1997,336:1014-1016.
8Li JJ, Cheng MZ, Cheng X. Rapid effects on lipid profile and C-reactive protein by simvastatin in patients with hypercholesterolemia. Clin Catdiol,2003,26(9) :472 - 476.
9Li JJ, Cheng XJ. Simvastatin inhibits interleukin - 6 release in human cultured monocytes stimulated by C-reactive protein as well as lipopolysaccharide. Coron Artery Dis. 2003.14:329 - 334.
10Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease. Med Hypotheses,2004,6:499-506.
